Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.

Falconi M, Bartsch DK, Eriksson B, Klöppel G, Lopes JM, O'Connor JM, Salazar R, Taal BG, Vullierme MP, O'Toole D; Barcelona Consensus Conference participants.

Neuroendocrinology. 2012;95(2):120-34. doi: 10.1159/000335587. Epub 2012 Feb 15. No abstract available.

2.

Multivisceral resection of pancreatic neuroendocrine tumours: a report of two cases.

Gundara JS, Alvarado-Bachmann R, Williams N, Gananadha S, Gill A, Hugh TJ, Samra JS.

World J Surg Oncol. 2011 Aug 22;9:93. doi: 10.1186/1477-7819-9-93.

3.
4.

TNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas--a single-institution experience.

Sellner F, Thalhammer S, Stättner S, Karner J, Klimpfinger M.

J Surg Oncol. 2011 Jul 1;104(1):17-21. doi: 10.1002/jso.21889. Epub 2011 Feb 24.

PMID:
21360536
5.

Celiaco-mesenterial arterial aberrations in patients undergoing extended pancreatic resections: correlation of CT angiography with findings at surgery.

Egorov VI, Yashina NI, Fedorov AV, Karmazanovsky GG, Vishnevsky VA, Shevchenko TV.

JOP. 2010 Jul 5;11(4):348-57.

6.

Celiac axis and common hepatic artery variations in 5002 patients: systematic analysis with spiral CT and DSA.

Song SY, Chung JW, Yin YH, Jae HJ, Kim HC, Jeon UB, Cho BH, So YH, Park JH.

Radiology. 2010 Apr;255(1):278-88. doi: 10.1148/radiol.09090389.

PMID:
20308464
7.

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

Garcia-Carbonero R, Capdevila J, Crespo-Herrero G, Díaz-Pérez JA, Martínez Del Prado MP, Alonso Orduña V, Sevilla-García I, Villabona-Artero C, Beguiristain-Gómez A, Llanos-Muñoz M, Marazuela M, Alvarez-Escola C, Castellano D, Vilar E, Jiménez-Fonseca P, Teulé A, Sastre-Valera J, Benavent-Viñuelas M, Monleon A, Salazar R.

Ann Oncol. 2010 Sep;21(9):1794-803. doi: 10.1093/annonc/mdq022. Epub 2010 Feb 5. Review.

8.

Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan.

Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M.

J Gastroenterol. 2010 Feb;45(2):234-43. doi: 10.1007/s00535-009-0194-8.

PMID:
20058030
9.

Vascular anomalies encountered during pancreatoduodenectomy: do they influence outcomes?

Shukla PJ, Barreto SG, Kulkarni A, Nagarajan G, Fingerhut A.

Ann Surg Oncol. 2010 Jan;17(1):186-93. doi: 10.1245/s10434-009-0757-1. Epub 2009 Oct 17. Review.

PMID:
19838756
10.

Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome.

Hartwig W, Hackert T, Hinz U, Hassenpflug M, Strobel O, Büchler MW, Werner J.

Ann Surg. 2009 Jul;250(1):81-7. doi: 10.1097/SLA.0b013e3181ad657b.

PMID:
19561478
11.

Neuroendocrine tumor epidemiology: contrasting Norway and North America.

Hauso O, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, Modlin IM.

Cancer. 2008 Nov 15;113(10):2655-64. doi: 10.1002/cncr.23883.

12.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB.

J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377. Review.

PMID:
18565894
13.

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.

Halfdanarson TR, Rabe KG, Rubin J, Petersen GM.

Ann Oncol. 2008 Oct;19(10):1727-33. doi: 10.1093/annonc/mdn351. Epub 2008 May 30.

14.

Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.

Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, Büchler MW.

Br J Surg. 2008 May;95(5):627-35. doi: 10.1002/bjs.6051.

PMID:
18306152
15.

Lessons learned from anatomic variants of the hepatic artery in 1,081 transplanted livers.

López-Andújar R, Moya A, Montalvá E, Berenguer M, De Juan M, San Juan F, Pareja E, Vila JJ, Orbis F, Prieto M, Mir J.

Liver Transpl. 2007 Oct;13(10):1401-4.

16.

CT angiography for delineation of celiac and superior mesenteric artery variants in patients undergoing hepatobiliary and pancreatic surgery.

Winston CB, Lee NA, Jarnagin WR, Teitcher J, DeMatteo RP, Fong Y, Blumgart LH.

AJR Am J Roentgenol. 2007 Jul;189(1):W13-9.

PMID:
17579128
17.

Resection of pancreatic neuroendocrine tumors: results of 70 cases.

Kazanjian KK, Reber HA, Hines OJ.

Arch Surg. 2006 Aug;141(8):765-9; discussion 769-70.

PMID:
16924083
18.

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.

Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, Di Fonzo M, Tornatore V, Milione M, Angeletti S, Cattaruzza MS, Ziparo V, Bordi C, Pederzoli P, Delle Fave G.

Endocr Relat Cancer. 2005 Dec;12(4):1083-92.

19.

Endocrine pancreatic tumors: factors correlated with survival.

Tomassetti P, Campana D, Piscitelli L, Casadei R, Santini D, Nori F, Morselli-Labate AM, Pezzilli R, Corinaldesi R.

Ann Oncol. 2005 Nov;16(11):1806-10. Epub 2005 Aug 5.

20.

Neuroendocrine tumours of the pancreas: predictors of survival after surgical treatment.

Jarufe NP, Coldham C, Orug T, Mayer AD, Mirza DF, Buckels JA, Bramhall SR.

Dig Surg. 2005;22(3):157-62. Epub 2005 Jul 20.

PMID:
16043962
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk